PAPER
Diastereoselective Two-Step Synthesis of Tricyclic Systems
977
(4a-Methyl-1-oxo-1,2,3,4a,5,8,8a,9-octahydrocyclopen-
ta[b]chromene-6,7-diyl)bis(methylene) Diacetate (5e)
Eluent: Et2O–EtOAc (1:1); yield: 123 mg (0.35 mmol, 41%); yel-
low oil; Rf = 0.28 (Et2O–EtOAc, 1:1).
(20 mL). The aqueous phase was extracted with CH2Cl2
(3 × 20 mL) and the combined organic phases were dried (MgSO4).
After filtration and evaporation of the solvent, the residue was puri-
fied by flash chromatography on silica gel.
IR (KBr): 3461, 2926, 1739, 1693, 1630, 1441, 1401, 1380, 1297,
1234, 1159, 1114, 1079, 1052, 1026, 985, 962, 881, 830 cm–1.
1H NMR (300 MHz, CDCl3): d = 4.63–4.51 (m, 4 H), 2.51–2.49 (m,
2 H), 2.43–2.38 (m, 3 H), 2.30–2.24 (m, 3 H), 2.04 (s, 3 H), 2.01 (s,
3 H), 2.00–1.93 (m, 3 H), 1.33 (s, 3 H).
13C NMR (75 MHz, CDCl3): d = 204.1, 182.6, 170.7, 129.7, 127.6,
112.5, 80.3, 63.0, 62.8, 37.7, 33.2, 32.7, 31.5, 26.6, 20.8, 20.3.
Dimethyl (7E,9E)-5a-Methyl-1-oxo-2,3,4,5a,6,11,11a,12-octa-
hydro-1H-cycloocta[b]chromene-8,9-dicarboxylate (6a)
Eluent: Et2O–EtOAc (10:1); yield: 115 mg (0.32 mmol, 49%);
white solid; mp 93–95 °C; Rf = 0.29 (Et2O–EtOAc, 10:1).
IR (KBr): 3425, 2949, 1724, 1648, 1623, 1437, 1391, 1352, 1266,
1188, 1134, 1098, 1062, 1043, 1015, 1001, 924, 839, 805, 771, 752
cm–1.
MS (EI, 70 eV): m/z (%) = 348 (1, [M]+), 288 (11), 246 (3), 228
(100), 213 (8), 199 (5), 185 (7), 171 (5), 158 (4), 149 (10), 135 (28),
118 (78), 105 (32), 91 (33), 77 (14), 65 (7), 55 (13).
1H NMR (300 MHz, CDCl3): d = 7.22–7.16 (m, 1 H), 7.09–7.04 (m,
1 H), 3.73 (s, 6 H), 2.82–2.32 (m, 7 H), 2.25–1.86 (m, 6 H), 1.30 (s,
3 H).
13C NMR (75 MHz, CDCl3): d = 198.1, 168.8, 166.4, 144.4, 140.5,
130.4, 129.3, 107.7, 124.7, 76.1, 52.2, 52.0, 40.4, 36.7, 34.7, 31.6,
28.7, 28.5, 28.1, 25.7, 20.9, 20.8.
MS (EI, 70 eV): m/z (%) = 360 (8, [M]+), 345 (1), 328 (65), 313 (9),
300 (16), 287 (23), 268 (28), 253 (6), 241 (29), 225 (9), 213 (8), 203
(17), 189 (32), 177 (59), 163 (100), 145 (33), 128 (18), 117 (60),
105 (27), 91 (48), 77 (38), 59 (42).
HRMS: m/z [M]+ calcd for C19H24O6: 348.1573; found: 348.1564.
10a-Methyl-7-phenyl-2,3,4,5,8,8a,9,10a-octahydro-1H-xan-
then-1-one (5f)
Eluent: Et2O; yield: 255 mg (0.87 mmol, 50%); yellow oil; Rf = 0.48
(Et2O).
IR (KBr): 3027, 2917, 1739, 1654, 1624, 1493, 1446, 1386, 1325,
1291, 1250, 1223, 1184, 1134, 1087, 1070, 998, 920, 851, 759, 699
cm–1.
HRMS: m/z [M]+ calcd for C20H24O6: 360.1573; found: 360.1578.
1H NMR (300 MHz, CDCl3): d = 7.34–7.15 (m, 5 H), 5.25 (s, 1 H),
2.48–2.44 (m, 2 H), 2.41–2.40 (m, 2 H), 2.35–2.31 (m, 1 H), 2.29–
2.24 (m, 2 H), 2.04–1.99 (m, 2 H), 1.96–1.87 (m, 4 H), 1.62 (s, 3 H).
13C NMR (75 MHz, CDCl3): d = 198.4, 169.9, 144.5, 132.9, 128.5,
127.3, 125.3, 124.7, 117.0, 110.5, 81.0, 36.8, 36.7, 32.8, 28.7, 23.2,
22.0, 21.0.
Dimethyl (7E,9E)-3,3,5a-Trimethyl-1-oxo-2,3,4,5a,6,11,11a,12-
octahydro-1H-cycloocta[b]chromene-8,9-dicarboxylate (6b)
Eluent: Et2O–EtOAc (10:1); yield: 156 mg (0.40 mmol, 52%);
white solid; mp 77 °C; Rf = 0.40 (Et2O–EtOAc, 10:1).
IR (KBr): 3417, 2954, 1724, 1628, 1437, 1393, 1347, 1264, 1135,
1099, 1061, 1044, 1010, 970, 936, 886, 851, 806, 772, 751 cm–1.
MS (EI, 70 eV): m/z (%) = 294 (4, [M]+), 226 (5), 182 (5), 170 (51),
155 (65), 141 (13), 126 (100), 115 (20), 102 (5), 91 (35), 77 (21), 65
(8), 55 (15).
1H NMR (300 MHz, CDCl3): d = 7.22–7.16 (m, 1 H), 7.08–7.02 (m,
1 H), 3.74–3.71 (m, 6 H), 2.89–2.40 (m, 4 H), 2.22–2.20 (m, 4 H),
2.02–1.57 (m, 3 H), 1.30 (s, 3 H), 1.04–0.98 (m, 6 H).
13C NMR (75 MHz, CDCl3): d = 197.8, 167.2, 166.4, 144.3, 140.4,
130.3, 129.3, 106.4, 124.7, 76.2, 52.1, 52.0, 50.6, 42.3, 40.4, 34.6,
32.2, 31.6, 28.9, 28.1, 27.7, 25.5.
MS (EI, 70 eV): m/z (%) = 388 (15, [M]+), 373 (3), 356 (64), 341
(31), 324 (33), 313 (21), 296 (42), 281 (16), 269 (41), 253 (13), 241
(8), 229 (12), 218 (11), 204 (34), 192 (98), 177 (100), 163 (41), 145
(46), 128 (25), 117 (80), 105 (36), 83 (63), 59 (52).
HRMS: m/z [M]+ calcd for C20H22O2: 294.1620; found: 294.1611.
6,10a-Dimethyl-2,3,4,5,8,8a,9,10a-octahydro-1H-xanthen-1-
one (5g)
Eluent: pentane–Et2O (1:2); yield: 196 mg (0.84 mmol, 49%); yel-
low oil; Rf = 0.50 (pentane–Et2O, 1:2).
IR (KBr): 3456, 2911, 1739, 1652, 1622, 1436, 1390, 1284, 1231,
1190, 1167, 1134, 1096, 1078, 1025, 994, 935, 855, 822, 796, 637
cm–1.
HRMS: m/z [M]+ calcd for C22H28O6: 388.1886; found: 388.1885.
1H NMR (300 MHz, CDCl3): d = 5.24 (s, 1 H), 2.37–2.24 (m, 6 H),
Dimethyl (6E,8E)-4a-Methyl-1-oxo-1,2,3,4a,5,10,10a,11-octa-
hydrocycloocta[e]cyclopenta[b]pyran-7,8-dicarboxylate (6c)
Eluent: Et2O–EtOAc (2:1); yield: 117 mg (0.34 mmol, 40%); white
solid; mp 96–98 °C; Rf = 0.19 (Et2O–EtOAc, 2:1).
2.07–2.01 (m, 2 H), 1.96–1.83 (m, 5 H), 1.61 (s, 3 H), 1.30 (s, 3 H).
13C NMR (75 MHz, CDCl3): d = 198.6, 169.9, 129.7, 118.2, 109.9,
78.6, 39.0, 36.6, 33.1, 29.3, 28.9, 24.9, 23.1, 21.5, 21.0.
MS (EI, 70 eV): m/z (%) = 232 (25, [M]+), 214 (38), 199 (7), 189
(5), 176 (3), 163 (14), 155 (2), 143 (5), 127 (7), 120 (60), 113 (87),
105 (39), 93 (100), 77 (32), 65 (13), 55 (16).
IR (KBr): 3435, 2951, 1723, 1635, 1440, 1403, 1339, 1266, 1244,
1141, 1095, 1075, 1059, 1038, 985, 938, 842, 806, 782, 772 cm–1.
1H NMR (300 MHz, CDCl3): d = 7.22–7.16 (m, 1 H), 7.11–7.05 (m,
1 H), 3.74–3.71 (m, 6 H), 2.88–2.81 (m, 1 H), 2.56–2.49 (m, 3 H),
2.42–2.37 (m, 2 H), 2.27–2.19 (m, 1 H), 2.18–1.99 (m, 2 H), 1.91–
1.85 (m, 1 H), 1.66–1.91 (m, 1 H), 1.34 (s, 3 H).
13C NMR (75 MHz, CDCl3): d = 203.9, 181.8, 166.4, 143.9, 140.1,
130.6, 129.5, 112.0, 111.2, 79.4, 52.1, 52.0, 40.1, 34.6, 33.3, 31.6,
28.1, 26.4, 25.0.
MS (EI, 70 eV): m/z (%) = 346 (9, [M]+), 314 (100), 299 (17), 286
(20), 273 (44), 254 (53), 239 (8), 227 (48), 213 (9), 203 (37), 189
(28), 177 (86), 163 (33), 150 (44), 141 (13), 128 (23), 117 (71), 105
(26), 91 (52), 77 (38), 59 (37).
HRMS: m/z [M]+ calcd for C15H20O2: 232.1463; found: 232.1460.
Preparative Knoevenagel-Hetero-Diels–Alder Multicomponent
Reaction of Cycloocta-1,3,6-trienes with Cyclic 1,3-Diones and
Formaldehyde; General Procedure
A Schlenk tube was charged with hydroquinone (5 mg, 0.043 mmol,
5 mol%), KOAc (9 mg, 0.086 mmol, 10 mol%), the appropriate cy-
clic 1,3-dione (0.86 mmol, 1.0 equiv), paraformaldehyde (52 mg,
1.72 mmol, 2.0 equiv), the appropriate cycloocta-1,3,6-triene 4
(1.98 mmol, 2.3 equiv) and glacial AcOH (1.0 mL). The mixture
was heated to 85 °C and stirred for 5 d until GC/MS-monitoring in-
dicated no further conversion of the cycloocta-1,3,6-triene 4. The
mixture was partitioned between CH2Cl2 (20 mL) and H2O
HRMS: m/z [M]+ calcd for C19H22O6: 346.1416; found: 346.1427.
Synthesis 2011, No. 6, 972–978 © Thieme Stuttgart · New York